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Abstract 
Coronary blood flow is tightly regulated to ensure that myocardial oxygen delivery meets local metabolic demand 
via the concurrent action of myogenic, neural, and metabolic mechanisms. While several competing hypotheses 
exist, the specific nature of the local metabolic mechanism(s) remains poorly defined. To gain insights into the 
viability of putative metabolic feedback mechanisms and into the coordinated action of parallel regulatory 
mechanisms, we applied a multi-scale modeling framework to analyze experimental data on coronary pressure, 
flow, and myocardial oxygen delivery in the porcine heart in vivo. The modeling framework integrates a 
previously established lumped-parameter model of myocardial perfusion used to account for transmural 
hemodynamic variations and a simple vessel mechanics model used to simulate the vascular tone in each of three 
myocardial layers. Vascular tone in the resistance vessel mechanics model is governed by input stimuli from the 
myogenic, metabolic, and autonomic control mechanisms. Seven competing formulations of the metabolic 
feedback mechanism are implemented in the modeling framework, and associated model simulations are 
compared to experimental data on coronary pressures and flows under a range of experimental conditions 
designed to interrogate the governing control mechanisms. Analysis identifies a maximally likely metabolic 
mechanism among the seven tested models, in which production of a metabolic signaling factor is proportional to 
MVO2 and delivery proportional to flow. Finally, the identified model is validated based on comparisons of 




The left ventricular myocardium extracts ~70-80% of the oxygen delivered from the arterial blood under normal 
resting conditions. A consequence of this high degree of myocardial oxygen extraction is that increases in 
myocardial oxygen demand (such as during exercise) require proportionate increases in perfusion to the 
myocardium to maintain adequate tissue oxygenation. This tight coupling of myocardial oxygen delivery with 
metabolism is observed to occur not only during physiologic increases in myocardial oxygen consumption 
(MVO2), but also following perturbations to coronary perfusion pressure (CPP), which are crucial, especially in 
response to proximal stenotic lesions of epicardial coronary arteries. 
Our understanding of the mechanisms underlying the balance between coronary blood flow and MVO2 remains 
limited. Putatively, coronary flow regulation is mediated via the concurrent action of three major control 
mechanisms: (1.) a myogenic mechanism where resistance arterioles constrict in response to increases in vascular 
wall tension; (2.) an autonomic mechanism were stimulation of β-receptors on arterial smooth muscle leads to 
vasodilation; and (3.) a metabolic mechanism where an increase in MVO2 promotes local vasodilation. These 
mechanisms work in parallel and converge on common end-effector pathways of coronary microvascular 
resistance; i.e. vascular smooth muscle tone. Moreover, the actions of these control mechanisms are influenced by 
structural and contractile properties of the myocardium and vary transmurally across layers of the myocardium. 
Precisely how these purported mechanisms work together dynamically and regionally, in the beating heart where 
cardiac contraction causes a constricting force on the vessels in the walls of the heart, impeding flow, particularly 
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in the subendocardium, during systole merits further investigation. Furthermore, while several competing 
hypotheses exist, the specific nature of local metabolic mechanism(s) remains poorly defined.  
The paradigm of local metabolic control of coronary blood flow centers around the hypothesis that vasoactive 
metabolites are produced in proportion to the prevailing level of myocardial oxygenation. This hypothesis is 
attractive in that it provides a mechanism directly linking increases in metabolism and reductions in tissue oxygen 
tension (typically index by coronary venous PO2) with commensurate changes in coronary blood flow [1]. 
However, this general framework offers little insight into if or how specific metabolites (e.g., adenosine and NO) 
or pathways (e.g., end-effector K+ channels) contribute to myocardial oxygen supply/demand balance. In 
addition, prior observations that coronary venous PO2 does not directly correlate with changes coronary blood 
flow during increases in MVO2 [2, 3] or perturbations in CPP [4] fail to support the metabolic hypothesis as 
proposed. Thus both the general framework of as well as the specific molecular signals involved in the local 
metabolic control of coronary blood flow continues to linger as one of, if not the most, highly contested mysteries 
of the coronary circulation to this day. 
The goal of this study is to address these knowledge deficits through model-based analysis of experimental data 
on in vivo coronary flow regulation in response to changes in perfusion pressure, MVO2, and the oxygen carrying 
capacity of the blood. Specifically, a multi-scale model of coronary flow regulation was constructed to account for 
putative myogenic, neural, and metabolic mechanisms as well as transmural dynamics of blood circulation and 
ventricular-vascular interactions. Model simulations were compared to data on coronary flow and zero-flow 
coronary pressure recordings obtained distal to epicardial occlusions in vivo in pigs [4] and subendocardial-to-
subepicardial flow ratio. Coronary flow and zero-flow pressure transients were obtained over a range of initial 
perfusion pressures and under control conditions as well as during hemodilution and hemodilution with 
dobutamine infusion.  
The model used to analyze these data is built based on the lumped three-layer model of myocardial perfusion [5] 
and the myogenic autoregulatory vessel model of Carlson and Secomb [6], with additional components 
representing β-mediated vasodilation and a metabolic feedback mechanism. Several competing representations of 
the metabolic mechanism were implemented and tested against the data. Using maximal-likelihood structural and 
parametric model identification to rule out and refine hypotheses, we identify a novel formulation of the 
metabolic mechanism in which the metabolic signal is represented as proportional to metabolic rate and flow. 
This mechanism can be interrupted as representing an ephemeral metabolic signal for which production is 
proportional to MVO2 and delivery proportional to flow. Potential candidates for such a signal include short-lived 
reactive species such as H2O2 [7]. The identified model is further validated based on comparisons of simulations 
to data on the myocardial perfusion response to conscious exercise that were not used for model identification.  
Methods 
Experimental Data for Model Identification and Validation 
Experimental data for model identification were obtained from prior studies on coronary blood flow 
autoregulation, including measurements of distal pressure transients in the left-anterior descending (LAD) arterial 
tree following proximal occlusion of the main LAD trunk in anesthetized pigs. The experimental details are 
described in Kiel et al. [4]. In brief, for a given experimental condition, the LAD was initially perfused at a 
constant baseline pressure by a servo-controlled pump. After a steady baseline flow at a given perfusion pressure 
was attained, the LAD trunk was occluded and the resulting decay in arterial pressure at a distal epicardial 
location was measured. The aortic pressure was continuously measured throughout the experiment via a femoral 
artery catheter. 
Example pressure transients obtained under control conditions (without dobutamine infusion or hemodilution) are 
illustrated in Figure 1A. In these data sets each of the six sub-panels in panel A corresponds to a different average 
initial perfusion pressure, ranging from 40 to 140 mmHg. The perfusion pressure oscillated around the set CPP 
level in-sync with the measured arterial pressure. The upstream occlusion is induced at time approximately t = 7 
seconds, resulting in a decay in pressure as blood drains from the arterial tree. The pressure oscillations, 
associated with myocardial contraction, continue during the decay. The final pressure attained after the 
approximately four-second transient decay is denoted the zero-flow pressure, Pzf, which is used as a metric of 
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myocardial resistance vessel tone. In our analysis we match model simulations to the full time course of the zero-
flow pressure experiment, as illustrated in Figure 1. 
Experiments from Kiel et al. also provide data on total flow (before occlusion) at each level of initial perfusion 
pressure, as illustrated in Figure 1B for the baseline experimental condition for an individual animal. Finally, our 
model identification is constrained to match the experimentally measured baseline subendocardial-to-
subepicardial flow ratio (ENDO/EPI), as illustrated in Figure 1B. 
The zero-flow pressure experiment was repeated under three different experimental conditions: (1) control; (2) 
hemodilution; and (3) hemodilution + dobutamine. Hemodilution was induced by gradually replacing equal 
volumes of blood with a synthetic plasma expander. Dobutamine was administered by an intravenous drip to 
increase heart rate to ~75–100% above baseline levels.  
Additional experimental data on conscious animals are used for validation. Briefly, animals were chronically 
instrumented with an arterial catheter, a perivascular flow transducer around the left anterior descending coronary 
artery, and with a solid state pressure transducer in the left ventricle as previously described [8]. Following 
recovery from surgery, hemodynamic variables were continuously measured under baseline resting conditions and 
subsequently during treadmill exercise. 
Overview of Model Formulation 
Coronary blood flow regulation is simulated by integrating a lumped model for myocardial perfusion in 
subendocardial, midwall, and subepicardial layers of the myocardium (Model 1) with a model of resistance vessel 
mechanics accounting for myogenic, autonomic, and metabolic regulatory mechanisms (Model 2). In practice, the 
integrated model is identified in a two-step process. First, the lumped model is fit to data from zero-flow pressure 
experiments, yielding estimates of vessel diameters as functions of transmural pressure in the different myocardial 
layers under different levels of perfusion pressure and oxygen demand, at different heart rates, and under different 
experimental conditions. Next, the vessel mechanics model (Model 2) identified by comparing a panel of model 
formulations representing competing hypotheses for the metabolic mechanism to estimated diameters obtained 
from Model 1. Finally, the identified vessel mechanics model is validated by combining the two models to 
simulate myocardial blood flow in exercise versus baseline resting conditions. 
Three-Layer Lumped Model of Myocardial Perfusion (Model 1) 
To simulate myocardial perfusion, we adapt the lumped model developed by Spaan et al. [9] and Mynard et al. [5, 
10], illustrated in Figure 2. For the zero-flow pressure experiments, this model is used to simulate constant-
pressure blood flow to the myocardium driven to the LAD by the extracorporeal servo-controlled pump, and the 
zero-flow pressure decay transient. The hydraulic properties of the perfusion tubing and epicardial vessels are 
governed by a series lumped resistance, blood inertance, and compliance, as illustrated in Figure 2. A venous 
resistance and compliance drain into the right-atrial pressure (PRA) downstream of a valve that prevents backflow 
in low perfusion pressures [11]. The myocardial circulation is divided to three parallel circuits representing 
subepicardial, midwall, and subendocardial layers. Within each layer, three serial resistances represent arterial, 
capillary, and venous compartments. Using Poiseuille resistance-volume relationship, the arterial and venous 
resistances (R1 and R2 in Figure 2) are computed 





, 𝑖𝑖 ∈ {1,2}, 𝑗𝑗 ∈ {1,2,3}, 1 
where 𝑅𝑅0,𝑖𝑖 and V0,𝑖𝑖 are reference resistance and volume, respectively, and the index j denotes myocardial layer: (1. 
subepicardial, 2. midwall, and 3. subendocardial). The instantaneous volume 𝑉𝑉𝑖𝑖𝑖𝑖  is (volume of compartment i in 
layer j) computed as 
 𝑉𝑉𝑖𝑖𝑖𝑖(𝑡𝑡) = min�𝑉𝑉0 + 𝐶𝐶𝑖𝑖𝑖𝑖𝑃𝑃𝑡𝑡𝑡𝑡,𝑖𝑖𝑖𝑖(𝑡𝑡),𝑉𝑉𝑐𝑐�, 2 
where transmural pressure (𝑃𝑃𝑡𝑡𝑡𝑡,𝑖𝑖𝑖𝑖) is the difference between to blood pressure (𝑃𝑃) and the intramyocardial 
pressure (𝑃𝑃𝑖𝑖𝑡𝑡,𝑖𝑖) [5]. Based on the analysis in [5], we assume  
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 𝑃𝑃𝑖𝑖𝑡𝑡,𝑖𝑖 = 1.2𝑑𝑑𝑖𝑖𝑃𝑃𝑙𝑙𝑙𝑙 3 
where 𝑑𝑑𝑖𝑖 is the relative depth of subendocardial (𝑑𝑑𝑖𝑖 = 5/6), midwall (𝑑𝑑𝑖𝑖 = 1/2) and subepicardial layers (𝑑𝑑𝑖𝑖 =
1/6). To estimate 𝑃𝑃𝑙𝑙𝑙𝑙, we use half-sine functions constrained to match the measured aortic pressure where 𝑃𝑃𝑙𝑙𝑙𝑙 =
𝑝𝑝𝑎𝑎𝑎𝑎 in the systolic phase and 𝑃𝑃𝑙𝑙𝑙𝑙 = 5mmHg in diastolic phase. An example estimated ventricular pressure time 
course and corresponding measured aortic pressure time course are illustrated in Supplementary Figure S1. 
This model formulation allows for a potential collapse of vessels in cases of largely negative transmural pressures. 
This collapse is prevalent in the subendocardial layer and is characterized with a transmural pressure below which 
the vascular volume remains almost constant (𝑉𝑉𝑐𝑐) [4, 12].  
Lastly, the middle resistance 𝑅𝑅𝑡𝑡𝑖𝑖  in each layer is computed using the resistance of the arterial and venous 
compartments 
 𝑅𝑅𝑡𝑡𝑖𝑖(𝑡𝑡) = 𝛾𝛾𝑅𝑅1j(𝑡𝑡) + (1 − 𝛾𝛾)𝑅𝑅2j(𝑡𝑡), 4 
where 𝛾𝛾 is a parameter between 0 and 1. To ensure a physiologically realistic transmural flow, the reference 
resistance 𝑅𝑅0,1 and the arterial compliances 𝐶𝐶1𝑖𝑖 are scaled with two factors: subepicardial to subendocardial 
resistance factor 𝑟𝑟𝑓𝑓 and compliance factor 𝑐𝑐𝑓𝑓. 
To simulate changes in vascular tone (dilation/constriction) in response to changes in CPP in the lumped model a 
factor is 𝑓𝑓𝐶𝐶𝐶𝐶𝐶𝐶  is used such that 
 𝐶𝐶1𝑖𝑖 = 𝑓𝑓𝐶𝐶𝐶𝐶𝐶𝐶 × 𝐶𝐶𝑖𝑖𝑖𝑖0 , 
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where 𝑓𝑓𝑖𝑖 > 1 represent vasodilation for CPP<100, 𝑓𝑓𝑖𝑖 < 1 vasoconstriction for CPP>100, and 𝐶𝐶𝑖𝑖𝑖𝑖0  is a reference 
value corresponding to the baseline conditions taken to be the CPP = 100 mmHg. The vasoreactivity factor is 
assumed to vary across different across the myocardium.  To incorporate graded vasoreactivity, a parameter 0 <
𝛽𝛽 < 1 is introduced such that 
 
𝑓𝑓1 = 𝑓𝑓𝐶𝐶𝐶𝐶𝐶𝐶 − 𝛽𝛽(𝑓𝑓𝐶𝐶𝐶𝐶𝐶𝐶 − 1) 
𝑓𝑓2 = 𝑓𝑓𝐶𝐶𝐶𝐶𝐶𝐶  
𝑓𝑓3 = 𝑓𝑓𝐶𝐶𝐶𝐶𝐶𝐶 + 𝛽𝛽(𝑓𝑓𝐶𝐶𝐶𝐶𝐶𝐶 − 1), 
6 
where 𝑓𝑓𝐶𝐶𝐶𝐶𝐶𝐶  is the overall vasoreactivity factor.  
To simulate the zero-flow pressure experiment, we divide the experiment to two parts: part 1 when the pump is 
driving flow to the LAD perfusion region; and part 2 when the pump is off and the extracorporeal circuit is 
clamped. To simulate first part of the experiment, we assume that the output pressure from the pump is constant 
and set to the nominal CPP for simulation time 0 < 𝑡𝑡 < 𝑡𝑡off, where 𝑡𝑡off when the pump is turned off and the 
extracorporeal circuit is clamped. For this first part of the experiment, the fixed driving pressure is used to drive 
the model and the resulting simulated flow is compared to the measured data. 
To simulate the second part of the experiment, flow is imposed, and the resulting pressure transient is simulated. 
Specifically, since the model cannot accommodate a step change in flow, a rapid continuous decrease to zero flow 
is imposed using the function 
 𝐹𝐹(𝑡𝑡) = 𝐹𝐹(𝑡𝑡off)𝑒𝑒−𝛼𝛼(𝑡𝑡−𝑡𝑡off), 𝑡𝑡 > 𝑡𝑡off. 
7 
The rate of decay is set to the value α = 10 sec-1, to obtain a decay to zero flow that is effectively instantaneous 
compared to the timescale of the observed pressure decay.  
Parameter Estimation for Model 1: Phasic tracings of perfusion pressure and flow for each experimental 
preparation are used to calibrate the myocardial circulation model. The perfusion pressure is measured 
continuously in both steps of the experiment using a cannula in the left anterior descending (LAD) coronary artery 
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in both steps of the experiment. Accordingly, in our model the pressure measurements correspond to 𝑃𝑃𝑖𝑖𝑖𝑖 in Figure 





where 𝑃𝑃𝑖𝑖𝑖𝑖𝑑𝑑𝑎𝑎𝑡𝑡𝑎𝑎 is the measured data at time 𝑡𝑡𝑘𝑘. The flow across 𝑅𝑅𝑝𝑝𝑎𝑎, 𝑞𝑞𝑖𝑖𝑖𝑖, is compared to the measured flow. Due to 





where 𝐹𝐹�𝑑𝑑𝑎𝑎𝑡𝑡𝑎𝑎 the average of flow before the extracorporeal circuit is clamped. The cost function for the parameter 
estimation is a weighted sum of the error in time-resolved pressure tracings, average flow before clamping the 
perfusion circuit, and a penalty term to ensure a physiological subendocardial to subepicardial flow ratio 
(ENDO/EPI) for each CPP level 
 𝐸𝐸𝐶𝐶𝐶𝐶𝐶𝐶 = 𝑤𝑤1𝒓𝒓𝒑𝒑𝑇𝑇𝒓𝒓𝒑𝒑 + 𝑤𝑤2𝑟𝑟𝑞𝑞2 + 𝑤𝑤3(𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐸𝐸𝑃𝑃𝐸𝐸⁄ − 1.25). 10 
The weights 𝑤𝑤1 and 𝑤𝑤2 are chosen such that the contribution of the pressure and flow to the cost function are the 
same order. The weight 𝑤𝑤3 is varied for CPP levels, assuming the largest weight for the CPP = 100 mmHg case, 
where the target ENDO/EPI ratio at rest is 1.25, reflecting the approximate average of values reported in the 
literature [13-15]. Finally, the total cost function for parameter estimation can be written as 
  𝐸𝐸1 = � 𝐸𝐸𝐶𝐶𝐶𝐶𝐶𝐶
𝐶𝐶𝐶𝐶𝐶𝐶
. 11 
In this work, the model parameters corresponding to the venous components of the model were fixed, and the 
arterial component parameters were adjusted to minimize the objective function 𝐸𝐸1. Table 1 lists the adjustable 
parameters and their description. 
Table 1. List of adjusted parameters for Model 1. 
Parameter Mean and (Range) of Estimated Values  Unit Description 
𝐿𝐿𝑝𝑝𝑎𝑎 1.737 (0.129-3.976) mmHg / (mL s-2) 
Blood inertance in perfusion circuit and 
epicardial vessels 
𝑅𝑅𝑝𝑝𝑎𝑎 2.729 (0.367-8.511) mmHg / (mL s-1) 
Resistance in perfusion circuit and epicardial 
vessels 
𝐶𝐶𝑝𝑝𝑎𝑎 0.0211 (0.009-0.042) mL / mmHg 
Compliance in perfusion circuit and epicardial 
vessels 
𝑉𝑉0 0.455 (0.218-0.643) mL Reference volume 
𝑉𝑉𝑐𝑐 0.194 (0.020-0.599) mL Collapsible volume 
𝑅𝑅0,3 104.00 (46.33-217.43) mmHg / (mL s-1) Reference subendocardial arterial resistance 
𝐶𝐶13 0.0044 (0.001-0.010) mL / mmHg Subendocardial arterial compliance 
𝑐𝑐𝑓𝑓 0.8686 (0.716-0.999) - 
The ratio of subepicardial to subendocardial 
compliance 
𝑟𝑟𝑓𝑓 1.4549 (2.047-1.006) - 
The ratio of subepicardial to subendocardial 
resistance 





7.11 (2.015-12.183),  
2.55 (1.163-6.221),  
0.38 (0.002-0.999),  
0.30 (0.003-0.999)] 
- Vasoreactivity factor for CPP=40,60,80,120,140 mmHg 
 
Representative Vessel Model (Model 2) 
In the representative vessel model, the arterial component in each layer is represented by a single vessel endowed 
with passive and active tension models as well as myogenic, metabolic, and autonomic regulatory mechanisms. 
Following [6, 16], the vessel wall tension is sum of a passive tension 𝑇𝑇𝑝𝑝𝑎𝑎𝑝𝑝𝑝𝑝 and an active tension 𝑇𝑇𝑎𝑎𝑐𝑐𝑡𝑡, which is the 
tension generated by the vascular smooth muscle cells (VSMs). The active tension is determined as the product of 
the maximal active tension 𝑇𝑇𝑎𝑎𝑐𝑐𝑡𝑡𝑡𝑡𝑎𝑎𝑚𝑚 in a given vessel and the activation level 𝐴𝐴. Thus, the vascular tension can be 
written as 
 𝑇𝑇 = 𝑇𝑇𝑝𝑝𝑎𝑎𝑝𝑝𝑝𝑝 + 𝐴𝐴 𝑇𝑇𝑎𝑎𝑐𝑐𝑡𝑡𝑡𝑡𝑎𝑎𝑚𝑚. 12 
The passive response of the vessel is expressed as a nonlinear function of diameter, by rearranging the nonlinear 











where 𝐴𝐴𝑝𝑝 and 𝐵𝐵𝑝𝑝 represent the asymptomatic maximum and minimum radii, 𝐶𝐶𝑝𝑝 is the bandwidth between 𝐴𝐴𝑝𝑝 and 
𝐵𝐵𝑝𝑝, and 𝜙𝜙𝑝𝑝 corresponds to the pressure offset determining the half-way point between 𝐴𝐴𝑝𝑝 and 𝐵𝐵𝑝𝑝. The maximal 
active tension generated by VSM is expressed by modifying the Gaussian function given in [6] so that the 
maximal possible active tension diminishes for small diameters. 
 𝑇𝑇𝑎𝑎𝑐𝑐𝑡𝑡𝑡𝑡𝑎𝑎𝑚𝑚 = 𝜌𝜌𝑡𝑡 𝐸𝐸/2 exp (−𝐶𝐶𝑡𝑡(𝐸𝐸/2− 𝜙𝜙𝑡𝑡)2) 
14 
Following [16], the activation level 𝐴𝐴 depends on the total stimulus 𝑆𝑆𝑡𝑡𝑎𝑎𝑖𝑖𝑡𝑡 in a sigmoidal manner 
 𝐴𝐴 =
1
1 + exp (−𝑆𝑆𝑡𝑡𝑎𝑎𝑖𝑖𝑡𝑡)
, 15 
where 𝑆𝑆𝑡𝑡𝑎𝑎𝑖𝑖𝑡𝑡 is a net summation of stimuli from the myogenic 𝑆𝑆𝑡𝑡𝑚𝑚𝑎𝑎, metabolic 𝑆𝑆𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎, autonomic 𝑆𝑆𝐻𝐻𝐻𝐻 
mechanisms, and an offset 𝐶𝐶0: 
 𝑆𝑆𝑡𝑡𝑎𝑎𝑖𝑖𝑡𝑡 = 𝑆𝑆𝑡𝑡𝑚𝑚𝑎𝑎 + 𝑆𝑆𝐻𝐻𝐻𝐻 + 𝑆𝑆𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎 + 𝐶𝐶0. 16 
We assume myogenic response is a linear function of the vascular tension, so we can write 
 𝑆𝑆𝑡𝑡𝑚𝑚𝑎𝑎 = 𝐶𝐶𝑡𝑡𝑚𝑚𝑎𝑎𝑇𝑇. 17 
The autonomic response is assumed to be a function of the heart rate and to have only dilatory effects on the 
myocardial vessels. Moreover, a baseline offset 𝐻𝐻𝑅𝑅0 is used to determine the threshold for autonomic signal 
generation. 
 𝑆𝑆𝐻𝐻𝐻𝐻 = −𝐶𝐶𝐻𝐻𝐻𝐻 max(𝐻𝐻𝑅𝑅 − 𝐻𝐻𝑅𝑅0, 0). 
18 
Similarly for metabolic mechanism, we assume the stimuli linearly depends on the signal 
 𝑆𝑆𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎 = −𝐶𝐶𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑀𝑀𝑆𝑆, 19 
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where 𝑀𝑀𝑆𝑆 is the metabolic signal, and the negative sign corresponds to a vasodilatory response.  
In this work we evaluated seven different representations of the metabolic signal: 
1. ATP-dependent (ATP): ATP release from red blood cells provides the metabolic feedback signal for local 
control of perfusion. The ATP transport model of Pradhan et al. [18] accounts for oxygen saturation-dependent 
leak of ATP from red blood cells and a flow-dependent washout of ATP from the circulation. From Pradhan et al., 
the metabolic signal is assumed proportional to venous ATP, which is governed by 





𝑆𝑆0 − 1�, 20 
where [𝐴𝐴𝑇𝑇𝑃𝑃]𝑙𝑙 and [𝐴𝐴𝑇𝑇𝑃𝑃]𝑎𝑎 are arterial and venous plasma ATP concentrations, 𝑉𝑉𝑐𝑐𝑎𝑎𝑝𝑝 is the capillary volume 
density, 𝐿𝐿𝑉𝑉𝑤𝑤 is the left ventricle weight, 𝐽𝐽0 is the ATP release rate in coronary vascular bed, and 𝑆𝑆0 is the ATP 
release parameter of the model.  
2. Myocardial oxygen consumption (MVO2): Myocardial oxygen consumption determines the metabolic 




× (𝐶𝐶𝐶𝐶𝐸𝐸2 − 𝐶𝐶𝐶𝐶𝐸𝐸2), 
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where 𝐶𝐶𝐶𝐶𝐸𝐸2 and 𝐶𝐶𝐶𝐶𝐸𝐸2 are the arterial and venous oxygen content. Experimental studies have shown that that 
myocardial fiber shortening and energy demands in subendocardium are higher than those of subepicardium [19]. 
This leads to variable oxygen consumption levels across the myocardium, with subendocardial to subepicardial 






















3. Oxygen extraction (𝑆𝑆𝑎𝑎 − 𝑆𝑆𝑙𝑙): The arterial-venous difference in oxygen saturation acts as a signal for 
metabolic control. 
 𝑀𝑀𝑆𝑆𝐸𝐸𝐸𝐸 = 𝑆𝑆𝑎𝑎 − 𝑆𝑆𝑙𝑙 23 
4. Layer-wise variable oxygen extraction (LSv ): The regional arterial-venous difference in oxygen saturation 
acts as a signal for metabolic control. Using the layer-wise MVO2, we compute venous oxygen saturation and 
arterial-venous oxygen extraction in each of three layers of the myocardium. 
 




, for  𝑗𝑗 ∈ {subendo. , midwall, subepi. }, 
𝑀𝑀𝑆𝑆𝐿𝐿𝑆𝑆𝑙𝑙 = 𝑆𝑆𝑎𝑎 − 𝑆𝑆𝑙𝑙𝑖𝑖 , 
24 
where 𝑐𝑐0 is the oxygen content of fully oxygen saturated oxyhemoglobin in a red blood cell. 
5. Flow times oxygen extraction (F∆S): The metabolic signal is the product flow and oxygen extraction in 
each layer of the myocardium. 
 𝑀𝑀𝑆𝑆𝑄𝑄Δ𝑆𝑆 = 𝐹𝐹𝑖𝑖 �𝑆𝑆𝑎𝑎 − 𝑆𝑆𝑙𝑙𝑖𝑖� , for  𝑗𝑗 ∈ {subendo. , midwall, subepi. }. 
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 𝑀𝑀𝑆𝑆𝐹𝐹M = 𝐹𝐹𝑖𝑖𝑀𝑀𝑉𝑉𝐸𝐸2𝑖𝑖 , for  𝑗𝑗 ∈ {subendo. , midwall, subepi. }. 
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7. Nonlinear metabolic rate model (MVO22): The metabolic signal is the square of the myocardial oxygen 
consumption rate. 
 𝑀𝑀𝑆𝑆𝑀𝑀𝑀𝑀𝑀𝑀22 = (𝑀𝑀𝑆𝑆𝑀𝑀𝑀𝑀𝑀𝑀2)2 
27 
Parameter Estimation for Model 2: Outputs of the parameterized Model 1, fit to data from the zero-flow pressure 
experiments, are used to estimate the layer-wise average diameters of representative resistance vessels, 𝐸𝐸�𝑖𝑖, for 
each experimental condition (control, hemodilution, hemodilution+dobutamine), each level of CPP, in each layer 
of the myocardium, and for each of four experimental animals. Additional inputs to Model 2 are average 
hemodynamics (pressure and flow) and estimated tissue pressures in each layer of the myocardium, blood 
oxygenation measurements, and heart rate.  
The layer-wise average flow 𝐹𝐹�𝑖𝑖, transmural pressure 𝑃𝑃𝑡𝑡𝑡𝑡,𝑖𝑖 , and resistance 𝑅𝑅�𝑖𝑖  are computed from the cycle 
averaged simulated of the lumped Model 1 under each experimental condition for each experimental animal. The 
estimated model-1 resistances 𝑅𝑅�𝑖𝑖 of the arterial components are used to determine representative vessel diameters: 











where the diameter of midwall at CPP=100 mmHg level is assumed to be 100 µm. The effective blood viscosity 𝜇𝜇 
determined as a function of hematocrit using the relation [21]: 
 𝜇𝜇 =  2.03 ⋅ exp[(0.0322 − 1.08e-4 ⋅ 𝑇𝑇𝑒𝑒𝑇𝑇𝑝𝑝) ⋅ 𝐻𝐻𝑐𝑐𝑡𝑡 − 0.02 ⋅ 𝑇𝑇𝑒𝑒𝑇𝑇𝑝𝑝 ], 29 
where 𝐻𝐻𝑐𝑐𝑡𝑡 and 𝑇𝑇𝑒𝑒𝑇𝑇𝑝𝑝 are hematocrit and temperature, respectively. 
Figure 3A shows how the estimated representative vessel diameter varies with transmural pressure in the midwall 
layer of an individual animal for the three different experimental conditions. To match the predictions of the 
vessel model (Model 2) to these estimated diameters, the following objective function is used for parameter 
estimation 
 𝐸𝐸2 = �𝑫𝑫�𝑖𝑖𝑀𝑀𝑎𝑎𝑑𝑑𝑡𝑡𝑙𝑙 2 − 𝑫𝑫�𝑖𝑖𝑀𝑀𝑎𝑎𝑑𝑑𝑡𝑡𝑙𝑙 1�, 
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where 𝑫𝑫�𝑖𝑖𝑀𝑀𝑎𝑎𝑑𝑑𝑡𝑡𝑙𝑙 1 = [𝑫𝑫�𝑖𝑖𝑐𝑐𝑎𝑎𝑖𝑖𝑡𝑡𝑐𝑐𝑎𝑎𝑙𝑙,𝑫𝑫�𝑖𝑖𝑎𝑎𝑖𝑖𝑡𝑡𝑡𝑡𝑖𝑖𝑎𝑎,𝑫𝑫�𝑖𝑖𝑎𝑎𝑖𝑖𝑡𝑡𝑡𝑡𝑖𝑖𝑎𝑎+𝑑𝑑𝑎𝑎𝑑𝑑𝑑𝑑𝑡𝑡𝑎𝑎𝑡𝑡𝑖𝑖𝑖𝑖𝑡𝑡] is the vector of computed diameters representing the 
same pig/same layer, and 𝑫𝑫�𝑖𝑖𝑀𝑀𝑎𝑎𝑑𝑑𝑡𝑡𝑙𝑙 2 is the corresponding Model 2 predictions. The adjustable parameters are listed 
in Table 2. 
Table 2. List of adjustable parameters for Model 2 
Parameter Subepicardial*  Midwall*  Subendocardial*  Unit Description 
𝐴𝐴𝑝𝑝 103.639 88.173 91.765 - Maximum asymptotic radius 
𝐵𝐵𝑝𝑝 12.653 17.925 19.225 - Minimum asymptotic radius 
𝐶𝐶𝑝𝑝 13.310 4.171 30.677 mmHg 
Bandwidth between 𝐴𝐴𝑝𝑝 and 
𝐵𝐵𝑝𝑝 
𝜙𝜙𝑝𝑝 2.212 -5.933 -14.544 mmHg Pressure offset 
𝜌𝜌𝑡𝑡 344.551 302.345 164.330 mmHg Magnitude of active tension 
𝐶𝐶𝑡𝑡 86.355 77.231 133.991 - Spread of Gaussian 
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𝜙𝜙𝑡𝑡 142.857 126.668 112.545 - Center of Gaussian 
𝐶𝐶𝑡𝑡𝑚𝑚𝑎𝑎 22.554 11.446 10.776 mmHg-1 Myogenic coefficient 
𝐶𝐶𝐻𝐻𝐻𝐻 0.026 0.034 0.081 min Autonomic coefficient 
𝐻𝐻𝑅𝑅0 92.302 79.642 75.657 min-1 Heart rate offset 
𝐶𝐶𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎 0.467 0.196 0.195 
[Model 
dependent] Metabolic coefficient 
𝑆𝑆0 0.0157 0.0100 0.0133 - 
ATP release parameter (only 
for ATP-dependent case) 
𝐶𝐶0 -6.351 -2.429 -0.752 - Tone offset 
* Mean parameter estimate listed for the top-ranked model, except for S0, which is a parameter only for the ATP-dependent model 
Model 2 model selection: The parameter estimation is repeated using each of the seven different metabolic signal 
models. To compare the performance of each model formulation, we use a modified second order Akaike 
information criterion (AICc), which is used for model selection across multiple datasets with small sample size 
[22, 23]  
 𝐴𝐴𝐸𝐸𝐶𝐶𝑐𝑐 = Σ𝑖𝑖=1 𝑁𝑁 �𝑛𝑛𝑖𝑖 ⋅ 𝑙𝑙𝑛𝑛
𝑅𝑅𝑆𝑆𝑆𝑆
𝑛𝑛𝑖𝑖
� + 2𝐾𝐾𝐸𝐸 �
𝑛𝑛𝑡𝑡
𝑛𝑛𝑡𝑡 − 𝐾𝐾𝐸𝐸 − 𝐸𝐸
�, 31 
where 𝑅𝑅𝑆𝑆𝑆𝑆 is the residual sum of squares (𝑅𝑅𝑆𝑆𝑆𝑆 = 𝐸𝐸22), 𝐾𝐾 is the number of parameters, 𝐸𝐸 is the number of data 
sets (4 pigs x 3 layers = 12 datasets), and 𝑛𝑛𝑖𝑖 is the number of data points in each data set (Pig 1: 15, Pig 2: 12, Pig 
3: 18, Pig 4: 18) and 𝑛𝑛𝑡𝑡 is the total number of data points (63). Then, a parameter ∆ for each is computed as 
 Δ𝑘𝑘 = 𝐴𝐴𝐸𝐸𝐶𝐶𝑐𝑐𝑘𝑘 − 𝐴𝐴𝐸𝐸𝐶𝐶𝑐𝑐𝑡𝑡𝑖𝑖𝑖𝑖 , 
32 
where AICck is the Akaike criterion for kth model, and AICcmin is the minimum AICc value. Finally, the relative 
likelihood (RLi), is given by 
 𝑅𝑅𝐿𝐿𝑘𝑘 = 𝑒𝑒𝑒𝑒𝑝𝑝(−0.5Δ𝑘𝑘), 33 
which is the probability that a particular kth model is a better model than the model with the minimum AICc value. 
Simulating Coronary Flow in Rest versus Exercise Conditions 
Once the coronary flow regulation model is constructed, the identified model framework, with Models 1 and 2 
integrated together, is validated by simulating in vivo myocardial perfusion in resting and exercise conditions. 
These simulations are compared to data collected in conscious animals, for which aortic and left ventricular 
pressure and LAD flow were simultaneously measured. The measured aortic pressure was used to drive the 
model, and simulations of LAD flow compared to data. Since the parametric identification from the zero-flow 
pressure experiments yields different optimal parameter values for each individual animal, and since the 
conscious exercise experiments were conducted on different animals and under different experimental conditions, 
a subset of parameters was identified to adjust to match the conscious state data. The model formulation is 
validated by showing that the model formulation using the top-ranked metabolic mechanism is able to match the 
conscious state data markedly better than lower ranked models.  
To simulate myocardial perfusion in vivo the two model components are simulated iteratively until they reach 
convergence. The measured aortic and left ventricular pressure data are inputs to Model 1 for a given set values of 
resistance vessel parameter values, 𝐶𝐶11, 𝐶𝐶12, and 𝐶𝐶13,   representing vessel tones in the three myocardial layers. 
The predicted flow from Model 1, along with the given measured heart rate and estimated MVO2, is used to 
compute the metabolic signal for use with Model 2. Model 2 is simulated to estimate the vessel diameters in each 















⇒ 𝐶𝐶1𝑖𝑖 = (�
𝑅𝑅0
𝑅𝑅�𝑖𝑖
V0 − V0)/𝑃𝑃�𝑡𝑡𝑡𝑡,𝑖𝑖. 
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The computed compliance values are fed back into Model 1, and the iterative process is carried out until Models 1 
and 2 agree and the predicted hemodynamic state reaches convergence. 
To calibrate the model to simulate exercise, we perform the following analysis to identify a set of adjustable 
parameters that satisfy two criteria: (1.) parameters in the set are estimated from the zero-flow pressure 
experiments with a relatively high degree of uncertainty; (2.) simulations of in vivo myocardial perfusion are 
sensitive to the values of parameters in the set of identified parameters. 
The uncertainty of the values estimated from the zero-flow pressure experiments is quantified based on the 
coefficient of variation 𝐶𝐶𝐶𝐶𝑉𝑉  




where 𝜎𝜎 and 𝜇𝜇 are the standard deviation and average of parameter 𝜃𝜃 used in Model 2. Next, we calculate 




|𝒑𝒑𝑖𝑖(𝜃𝜃 + 0.1𝜃𝜃) − 𝒑𝒑𝑖𝑖(𝜃𝜃)| 36 
where prediction vectors 𝒑𝒑𝒊𝒊 are simulation results; 𝒑𝒑1 = 𝐹𝐹𝑐𝑐𝑡𝑡𝑝𝑝𝑡𝑡(𝒕𝒕),𝒑𝒑2 = 𝐹𝐹𝑡𝑡𝑚𝑚𝑡𝑡𝑐𝑐.(𝒕𝒕),  𝒑𝒑3 = (𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐸𝐸𝑃𝑃𝐸𝐸⁄ )𝑐𝑐𝑡𝑡𝑝𝑝𝑡𝑡 , 𝒑𝒑4 =
(𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐸𝐸𝑃𝑃𝐸𝐸⁄ )𝑡𝑡𝑚𝑚𝑡𝑡𝑐𝑐.  correspond to flow and ENDO/EPI flow ratio in rest and exercise. Finally, the model 
sensitivity 𝑆𝑆 to each parameter is computed is the sensitivity of each prediction 
 𝑆𝑆(𝜃𝜃) = �‖𝑿𝑿𝑖𝑖(𝜃𝜃)‖
𝑖𝑖
, 37 
To find the set of adjustable parameters, we find the parameters 𝜃𝜃 with 𝐶𝐶𝐶𝐶𝑉𝑉(𝜃𝜃) > 30% and 𝑆𝑆(𝜃𝜃) > 0.1. To 












where 𝐹𝐹𝑐𝑐𝑡𝑡𝑝𝑝𝑡𝑡𝑑𝑑𝑎𝑎𝑡𝑡𝑎𝑎 and 𝐹𝐹𝑡𝑡𝑚𝑚𝑡𝑡𝑐𝑐.𝑑𝑑𝑎𝑎𝑡𝑡𝑎𝑎 are LAD flow data in rest and exercise. Then, the cost function for the parameter 
estimation is 
𝐸𝐸3 = 𝑤𝑤𝑓𝑓(𝒓𝒓𝒓𝒓𝑇𝑇𝒓𝒓𝒓𝒓 + 𝒓𝒓𝒆𝒆𝑇𝑇𝒓𝒓𝒆𝒆) + 𝑤𝑤𝑡𝑡|(𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐸𝐸𝑃𝑃𝐸𝐸⁄ )𝑐𝑐𝑡𝑡𝑝𝑝𝑡𝑡 − 1.2|, 
with weights 𝑤𝑤𝑓𝑓 and 𝑤𝑤𝑡𝑡. 
Results 
Model 1 Identification  
Figure 1 shows an example data set for the zero-flow pressure experiment along with a fit of model 1 for an 
individual animal under control conditions. The top two rows show the pressure tracings at different levels of 
CPP. At roughly t = 7 seconds, the LAD flow is occluded and the decay of pressure at a distal site is recorded for 
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approximately 4 seconds. The bottom panels show data and model predictions of average flow and ENDO/EPI 
flow ratio measured before the occlusion. Supplementary Figures S2-S13 show model fits to the zero-flow 
pressure time course data for all animals and experimental conditions. 
Figure 4 shows the measured and model-predicted total flow data for the four individual pigs for the three 
different experimental preparations. In control and hemodilution conditions flow is maintained at roughly 
constant values over an autoregulatory range of CPP values between 60 and 120 mmHg. The total flow is elevated 
in hemodilution compared to control, in order to maintain oxygen delivery. Infusion of dobutamine significantly 
increases the flow compared to the control and hemodilution conditions and tends to abolish the autoregulatory 
response in all animals. 
The Model-1 fits yield estimates of resistance vessel diameter at each CPP level under each experimental 
condition for each animal. These diameter estimates are illustrated in Figure 3 for all three experimental 
conditions for the midwall layer for one experimental animal. Analogous predictions for all myocardial layers and 
for all animals are plotted in Supplementary Figures S14-S25.  
Model 2 (Representative Vessel Model) Identification  
As illustrated in Figure 3A and in Supplementary Figures S14-S25, Model 1 yields estimates of resistance vessel 
diameter as functions of transmural vessel pressure for three different experimental conditions, for three 
myocardial layers, and four individual animals at each of six values of CPP. Each of the seven competing versions 
of Model 2 (representing different formulations of the metabolic mechanism) are fit to this data set to determine 
the most likely model best able to represent the data. Example fits, associated with the flow-times-MVO2 
metabolic mechanism, are shown in Figure 3A.  
Table 3 lists the estimated AICck, ∆k, and RLk values for the seven models, illustrating that the flow-times-MVO2 
metabolic mechanism is the highest ranked model, identified as the maximally likely among the models tested. 
Table 3. Models are ordered by their AICc value with the best model ranked 1. 
Metabolic Signal # Metabolic Signal AICck Δk RLk Rank 
6 F⸱M, flow times MVO2 542 0 1.00 1 
5 F⸱∆S, flow times oxygen extract. 556 14 2.86e-02 2 
2  MVO2, metabolic rate 610 68 4.66e-08 3 
3 Sv, venous oxygen saturation 614 72 1.68e-08 4 
4 LSv, Regionally varying Sv 617 75 8.14e-09 5 
1 ATP, ATP release from RBC’s 627 85 5.62e-10 6 
7 MVO2
2
, nonlinear metabolic 688 146 1.50e-16 7 
 
Figure 3 also plots the regulatory signals predicted by the model for the fits to the midwall myocardial layer show 
in panel A. For all three experimental conditions, the resistance vessel constricts with increasing the transmural 
pressure. In control and hemodilution conditions, the total activation level 𝐴𝐴 steadily increases from 0 for low 
CPPs (full dilation) to 0.8-0.9 for high CPPs. With the addition of dobutamine, the overall activation is shifted 
down. Panels C-E show the variation of each mechanism in response to changes in CPP and experimental 
conditions. The myogenic contribution increases with increasing the transmural pressure, with the greatest values 
in hemodilution+dobutamine case. The predicted autonomic contribution is nearly constant over the observed 
range of CPP because the heart rate is nearly constant for each experimental condition. The autonomic 
contribution is elevated in the hemodilution+dobutamine case due to a higher the heart rate for this condition 
compared to other cases.  
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The metabolic signal is predicted to be an order of magnitude smaller than the myogenic and autonomic signals 
for the midwall layer for this animal under these conditions. Panel C shows that the strongest contributor to the 
pressure autoregulatory response is the myogenic mechanism, with Smyo increasing from 0 at the lowest CPP to 8 
at the CPP = 140 mmHg (corresponding to average transmural pressure of approximately 60 mmHg in the 
midwall region). The autonomic signal makes the biggest contribution to increasing diameter under 
hemodilution+dobutamine compared to other cases. This prediction is similar to that of Pradhan et al. [18], who 
predicted that the open-loop autonomic signal contributes more to the response in coronary flow to increasing 
demand in exercise than the metabolic feedback signal. 
Figures 5, 6, and 7 illustrate how the predicted resistance vessel diameters and regulatory signals vary with CPP 
in each layer of the myocardium, summarizing predictions for all experimental animals. In the subepicardium 
(Figure 5), diameter decreases with increasing CPP under all experimental conditions. This trend is reversed in 
the subendocardium (Figure 7), where an increase in vasodilation with increasing perfusion pressure counters the 
action of increasing transmural pressure. In the hemodilution+dobutamine experiments, in particular (Figure 7B), 
the subendocardium is predicted to be nearly fully vasodilated across all values of CPP.  
As expected, the myogenic mechanism (panel C of Figure 5, 6, and 7), makes the greatest contribution to the 
pressure autoregulatory response in the subepicardium, and smaller contributions in the midwall and 
subendocardial layers. The autonomic signal contribution (panel D of Figure 5, 6, and 7) is not predicted to vary 
substantially with CPP, indicating that this signal does not represent an important factor in eliciting the pressure 
autoregulation response simulated here. This prediction is expected because heart rate does not substantially 
change with CPP in these experiments. Thus we conclude that sympathetic outflow to vascular smooth muscle 
also does not substantially change with CPP in these experiments. However, the baseline of the autonomic signal 
increases from the subepicardium to the subendocardium, indicating that the subendocardium may be more 
sensitive to changes in sympathetic tone that the other layers.  
In all layers the metabolic signal (panel E of Figure 5, 6, and 7) is predicted to make a far greater contribution to 
the vasoregulation in the hemodilution+dobutamine case compared to the other experimental conditions. In all 
layers the metabolic signal tends to increase with CPP, and tends to be slightly greater under hemodilution 
conditions compared to control. The magnitude of the increase with CPP is greatest for the 
hemodilution+dobutamine case because the oxygen demand is greatest in this condition. 
Model Validation: Simulating Exercise 
The ability of the top performing metabolic signal model, F⸱M, is validated by evaluating its ability to simulate 
coronary flow regulation in conscious resting versus exercise conditions. Figure 8 shows input data on aortic and 
left-ventricular pressures obtained under resting (panel A) and moderate treadmill exercise (2-4 mph, 0% grade, 
panel B). These pressure data are used to drive the model to match the measured LAD flows illustrated in Figure 
9.  
Under resting conditions, the animal’s heart rate was observed to be 84 beats min-1, with systolic and diastolic 
aortic pressures approximately 149 and 102 mmHg, with developed pressure in the ventricle matching peak 
systolic aortic pressure. During exercise heart rate increases to 114 beats min-1 and aortic pressures to 162 and 118 
mmHg. We assume a resting average myocardial oxygen consumption rate of 60 µL O2/min/g based on Kiel et al. 
(8). Based on the observed aortic pressures and heart rates, we estimate that left-ventricular mechanical power 
output increases by 32% in exercise compared to control [24]. And based on the expected linear scaling of power 
output and oxygen demand, we approximate the exercise oxygen consumption rate to be 79.2 µL O2/min/g in 
exercise. 
Given the measured driving pressures and the estimated myocardial oxygen consumption rates, the integrated 
model can be used to simulate myocardial perfusion in resting and exercise conditions. However, parameters 
estimated based on the zero-flow pressure experiments (Tables 1 and 2) show a degree of variability and 
uncertainty. Moreover, they are estimated for different individual animals. Thus, to match the conscious data of 
Figures 8 and 9, a subset of adjustable parameters was identified, as described in the methods. Adjustable 
parameters for the conscious experiments are listed in Table 4. 
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Table 4. List of adjustable parameters and estimated values for in vivo simulations 
Parameter Layer CoV Sensitivity Estimated Value 
𝜙𝜙𝑡𝑡 Midwall 0.3084 1.38 133.577 
𝐶𝐶𝑡𝑡𝑚𝑚𝑎𝑎 Midwall 0.3075 0.13 13.923 
𝐶𝐶0 Midwall 0.3405 2.07 -3.296 
𝜙𝜙𝑝𝑝 Subepicardial 7.6885 0.29 20.736 
𝜙𝜙𝑡𝑡 Subepicardial 0.3633 2.53 75.439 
𝐶𝐶𝑡𝑡 Subepicardial 0.5246 1.32 107.652 
𝐶𝐶𝑡𝑡𝑚𝑚𝑎𝑎 Subepicardial 0.3010 0.28 27.483 
𝐶𝐶0 Subepicardial 0.5264 0.46 -9.735 
 
Simulated total LAD flow, obtained using the identified F.M model, is compared to measured data for baseline 
rest (panel A) and exercise (panel C) conditions in Figure 9. The model effectively captures both the pulsatile 
nature of the flow and the dynamics of flow recruitment in exercise. Panels B and C of Figure 9 show the 
predicted flow to each of the three myocardial layers, revealing that that the subendocardial flow is positive only 
during diastole, and becomes negative during systole. In contrast, the subepicardial flow shows positive peaks 
during both systole and diastole. During exercise, when the driving aortic systolic pressure increases, the systolic 
peak becomes more important in the subepicardium.  
Model predictions of average flow and of the subendocardial-to-subepicardial perfusion ratio are compared to 
experimental data on Figure 10. In fitting the flow data, the model correctly predicts the transmural variations in 
perfusion in rest versus exercise. For comparison predictions associated with the best fit of the 𝑀𝑀𝑆𝑆𝐿𝐿𝑆𝑆𝑙𝑙 (ranked 5 in 
Table 3) model are shown in panels A and B. This model is able to match the measured flow, but in doing so 
predicts subendocardial-to-subepicardial perfusion ratios that are much lower than physiological. These results 
represent a validation of our identified model and of our model selection procedure. Moreover, the modeling 
framework provides predictions of transmural constriction/dilation of vessels in terms of their overall vascular 
tone (e.g., activation A), and normalized diameter (Figure 10 C & D). Subendocardial layer tone is predicted to 
decrease to almost full vasodilation in exercise while the subepicardial layer tone increases. The overall increase 
in tone in the subepicardial layer is overcome by the pressure-induced dilation (panel D). 
Figure 11 illustrates how each regulatory signal contributes to the overall predicted response to exercise. The 
figures plots the exercise-induced change in each stimuli (Δ𝑆𝑆 = 𝑆𝑆𝑡𝑡𝑎𝑎𝑖𝑖𝑡𝑡𝑡𝑡𝑚𝑚𝑡𝑡𝑐𝑐𝑐𝑐𝑖𝑖𝑝𝑝𝑡𝑡 − 𝑆𝑆𝑡𝑡𝑎𝑎𝑖𝑖𝑡𝑡𝑐𝑐𝑡𝑡𝑝𝑝𝑡𝑡 ) in each layer of the 
myocardium for the F.M model. The model-predicted vasoconstriction in the subepicardium in exercise is shown 
to be due to a myogenic response to elevated perfusion pressure. The autonomic vasodilation signal (SHR) is 
predicted to preferentially influences the subendocardium, with a negligible on the subepicardium. 
Discussion 
The physiological balance between coronary blood and myocardial oxygen consumption (MVO2) is preserved 
over a variety of physiological and pathophysiologic condition, including in the response to exercise where 
increases in oxygen demand are met by corresponding increases in oxygen delivery. 
Modeling framework and the overall approach – This study integrates a lumped approach to simulating 
ventricular-vascular interaction and myocardial perfusion adapted from Spaan et al. [9], and Mynard et al. [5, 10], 
a vasoregulation model adapted from Carlson et al. [6], and a panel of competing mechanisms representing 
metabolic control of myocardial blood flow. The multi-scale modeling framework is illustrated in Figure 2. The 
model components are identified based on analysis of data from zero-flow pressure experiments, as illustrated in 
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Figure 1. Based on their relative ability to match the experimental data, ranked based on goodness of fit and 
degrees of freedom in the models, the maximally likely metabolic mechanism is identified, and further validated 
based on simulations of conscious response to exercise (Figures 8, 9, and 10). One of the major novelties of our 
study is the application of established tools for model discrimination in the context of multi-scale systems with 
high degrees of uncertainly and structural and parametric freedom.  
Identification of hypothetical metabolic signal – Data from three conditions and four experimental animals were 
analyzed with model formulations that integrated seven competing hypotheses for the nature of the metabolic 
feedback signal. The competing hypotheses are summarized in Table 3, along with a summary ranking of most-
to-least likely mechanism. These results illustrate a combined structural and parametric model identification, with 
several competing models ruled out as not viable. In the top-ranked model, the metabolic signal is represented as 
proportional to metabolic rate and flow. Our preliminary interpretation of this result is that it represents an 
ephemeral metabolic signal for which production is proportional to MVO2 and delivery proportional to flow. 
Potential candidates for such a signal include short-lived reactive species such as H2O2 [7].  
Predicted resistance vessel diameters are plotted as functions of transmural pressure at different CPP values for 
the midwall layer in one experimental animal in Figure 4. Predicted diameters are plotted as functions of CPP for 
all animals under all conditions in Supplementary Figures S14-S25. Simulations consistently show a greater 
resistance vessel diameter for the hemodilution compared to control case. These differences are small but 
important because they are consistently required to match the data on flow and pressure. In fact, the reason why 
the ATP-mediated metabolic model (Metabolic Signal #1, Table 3) cannot effectively match data from the zero-
flow pressure experiment is that it cannot capture this phenomenon. In other words, even with arbitrarily adjusting 
parameters, the output of the model capturing the ATP hypothesis cannot be made to be consistent the observed 
pressure response to upstream occlusion. Therefore, by combining the lumped microcirculation model, a simple 
vessel mechanics model, and our ATP-mediated metabolic control model to analyze these data, our analysis 
argues against the hypothesis that ATP derived from red blood cells represents the primary metabolic signal for 
coronary blood flow regulation. Rigorously, discarded models are judged as non-viable only in the form that they 
are implemented for this analysis. Nevertheless, this finding highlights the sort of novel insight that comes from 
analyzing time-dependent data using even a relatively crude multi-scale and spatially distributed modeling 
framework.  
Thus although we do not interpret the top-ranked model as “proven” or “correct”, the disproof of the alternatives 
usefully narrows the scope of possibilities. Furthermore, even if the basic formulation of the F·M model correctly 
represents the basic action of metabolic mechanism, this analysis does not identify the molecular mechanism 
underlying the putative mechanism. Rather, we interpret the ephemeral metabolic signal F·M model as a working 
hypothesis to test and refine with further experiments and models that represent the metabolic and signaling 
mechanisms with more mechanistic resolution. The validity of this working hypothesis is supported by the ability 
of the associated model to simulate the response in myocardial perfusion to exercise. 
Matching demand in exercise – The ability of the ephemeral signal hypothesis, when integrated in this modeling 
framework, to effectively simulate the dynamics of myocardial perfusion in the transition from resting state to 
exercise is illustrated in Figures 8, 9, and 10. Because lower-ranked models (e.g., Metabolic Signal #5) predict a 
greater than physiological drop in subendocardial perfusion with exercise, these results represent a validation of 
the maximal-likelihood evaluation process: the top-ranked model captures behavior not used for identification, 
while lower ranked models fail. 
Simulation of the exercise response also yields novel hypotheses regarding the regional response to increasing 
exercise demand. For example, simulations predict that subepicardial vascular tone is higher during exercise than 
at rest, due to a myogenic response to elevated perfusion pressure. Another prediction associated with the exercise 
simulations is that sympathetic-mediated vasodilation preferentially influences the subendocardium. The 
physiological role of sympathetic activation in the control of myocardial perfusion is much more complex than 
the simplified way it is treated in the current model, which does not take into account a potentially heterogeneous 
distribution of α-mediated constriction effectors [2, 25]. Moreover, measurement of β2-adrenergic receptor 
densities show transmurally uniform expression in the human myocardium [26, 27]. Furthermore, subepicardial 
resistance arterioles from pig have been observed to show a greater vasodilation response to selective β2 
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stimulation and have greater β2 receptor density than subendocardial resistance arterioles [28]. At the same time, 
α-mediated vasoconstriction has been shown to preferentially distribute flow to the subendocardium, particularly 
during exercise and in the presence of a proximal stenosis [29]. Our model lumps α- and β-mediated effects on 
resistance vessels into a single signal, SHR. Thus the model prediction that the gain associated with this signal is 
greater in the subendo- compared to subepicardium is consistent with the interpretation that the overall response 
to sympathetic stimulation is relatively more vasodilatory in the subendocardium compared to the subepicardium. 
Moreover, this overall transmural gradient in the response of vascular tone in exercise is undoubtedly influenced 
by regional heterogeneities in responses of vessels of different sizes and transmural depth to metabolic, myogenic, 
and autonomic signals. A deeper investigation of how these factors work together in vivo may be possible by 
combining models with more anatomically resolved detail [30] with the regulatory mechanisms analyzed here. 
Limitations of the study –The current model uses a simplified lumped-parameter of myocardial circulation 
downstream of the LAD, capturing regional differences in perfusion only in terms of a relatively coarse 
representation of transmural heterogeneity in the LV free wall. Previous applications of this approach have 
coupled the myocardial perfusion model to a 1D hemodynamics models of epicardial vessels to simulate regional 
perfusion, for example in the left-ventricular free wall versus the septum [5, 10]. Moreover, the target transmural 
flow distribution (ENDO/EPI ratio) in the current study is estimated from literature reports, which consistently 
report ENDO/EPI at only one experimental point (control, CPP=100 mmHg). More data on variation of 
transmural perfusion with CPP would be valuable in constraining and testing model behavior. More broadly, a 
rigorous uncertainty quantification will be useful in analyzing measurement errors propagated to the final model 
predictions. Finally, the current model assumes the intramyocardial pressure is a linear function of left ventricular 
pressure in all cases. This assumption has to be re-examined especially for dobutamine experiments which 
involve elevations in the myocardial contractility which directly influences the intramyocardial pressure via 
changes in the myocyte shortening induced pressure [31]. 
 
Model Code Availability 
Computer codes, implemented in the MATLAB computing environment, are available for download from the 
repository at https://github.com/beards-lab/Multiscale-Coronary-Flow-Control. 
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Figures and Figure Legends 
 
 
Figure 1. An example data set used to identify Model 1 for an individual animal under control conditions. A. Pressure 
recordings obtained at 6 levels of CPP following occlusion of left anterior descending (LAD) artery. The artery is occluded at 
~7 sec and the decay distal to the occlusion is recorded. B. Total LAD flow, measured at different values of CPP. D. 
Myocardial subendocardial-to-subepicardial (ENDO/EPI) flow ratio before the occlusion. Data in Panels A and B are from 
Kiel et al. [4]. Measured ENDO/EPI flow ratio under baseline control conditions is targeted to 1.25 (see text for details). 








Figure 2. Schematic of the modeling approaches. Model 1: The myocardial circulation model which determines 
the flow and pressure in each layer of the myocardium. Model 2: A representative vessel model endowed with 





Figure 3. Vasoregulation as a function of transmural wall pressure. A. Model predictions of relative resistance 
vessel diameters are shown for the midwall layer for pig C for the midwall layer. Diameters for the three 
experimental conditions, associated with the fits of Model 1 to the zero-flow pressure experiment, are plotted as 
“+” markers: blue for control; green for hemodilution; and red for hemodilution + dobutamine. The matches of 
Model 2-based predictions (using the ‘F⸱M’, flow times MVO2, metabolic signal) to the diameter estimates are 
plotted as “o” markers connected by dashed lines. B. Predicted total smooth muscle activation is plotted as a 
function of transmural pressure in the zero-flow pressure experiment. C. Predicted myogenic activation signal is 
plotted as a function of transmural pressure in the zero-flow pressure experiment. D. Predicted autonomic 
activation signal is plotted as a function of transmural pressure in the zero-flow pressure experiment. E. Predicted 





Figure 4. Measured versus model-predicted LAD flow for each of four experimental animals under three different 
experimental conditions. In control and hemodilution conditions, coronary autoregulation impedes a significant 
increase in flow with increases in CPP (60-120 mmHg). However, the overall myocardial blood flow is elevated 
with hemodilution. Dobutamine infusion significantly increases the flow compared to the control and 








Figure 5. Vasoregulation in subepicardial vessels. A. Predicted mean and standard error of subepicardial 
resistance vessel diameter is plotted as a function of CPP. B. Predicted mean and standard error of total vessel 
activation is plotted as a function of CPP. C. Predicted mean and standard error of myogenic activation signal is 
plotted as a function of CPP. D. Predicted mean and standard error of autonomic activation signal is plotted as a 







Figure 6. Vasoregulation in midwall vessels. A. Predicted mean and standard error of subepicardial resistance 
vessel diameter is plotted as a function of CPP. B. Predicted mean and standard error of total vessel activation is 
plotted as a function of CPP. C. Predicted mean and standard error of myogenic activation signal is plotted as a 
function of CPP. D. Predicted mean and standard error of autonomic activation signal is plotted as a function of 




Figure 7. Vasoregulation in subendocardial vessels. A. Predicted mean and standard error of subepicardial 
resistance vessel diameter is plotted as a function of CPP. B. Predicted mean and standard error of total vessel 
activation is plotted as a function of CPP. C. Predicted mean and standard error of myogenic activation signal is 
plotted as a function of CPP. D. Predicted mean and standard error of autonomic activation signal is plotted as a 





Figure 8. Measured aortic and left-ventricular pressure time courses for a conscious pig in rest (left panel) and 
exercise (right panel). 
 
 
Figure 9. Coronary flow dynamics in rest versus exercise. A. Model-predicted total LAD flow under resting 
control conditions is compared to measured flow. B. Predicted contributions of subendocardial, midwall, and 
subepicardial flow to total LAD flow under resting conditions are shown. C. Model-predicted total LAD flow 
under exercise conditions is compared to measured flow. D. Predicted contributions of subendocardial, midwall, 
and subepicardial flow to total LAD flow under exercise conditions are shown. In both rest and exercise 
conditions the model simulations reflect the integrated model using the top-ranked using the ‘F⸱M’, flow times 




Figure 10. Regulation of coronary flow in exercise. A. Comparison of measured to model-predicted total LAD 
flow in resting versus exercise condition. B. Comparison of measured to model-predicted subendocardial-to-
subepicardial (ENDO/EPI) flow in resting versus exercise condition. In panels A and B fits from competing 
metabolic model are illustrated, showing that the lower ranking model fails to capture the ENDO/EPI flow ratio. 
C. Predicted total vascular tone activation in each layer of the myocardium for resting and exercise conditions. D. 




Figure 11. The change in total, myogenic, metabolic, and autonomic stimuli in response to exercise. The gray bars 
show the net total change in stimulus in each layer exercising compared to rest conditions. The individual 
contributors to the stimuli signal—myogenic, autonomic, and metabolic—sum to the total in each layer. The total 
stimulus in the subepicardium is higher in exercise than in rest, resulting in an increased activation. The primary 
contributor to the increased activation in the subepicardium in exercise is the myogenic stimulus. In the 
subendocardium exercise causes an overall reduction in vascular tone, caused by a combination of metabolic and 
autonomic stimuli. 
 
 
